| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 133.32B | 129.99B | 127.98B | 124.01B | 113.31B | 104.19B |
| Gross Profit | 43.54B | 38.81B | 37.98B | 39.59B | 38.57B | 33.77B |
| EBITDA | 8.72B | 7.47B | 5.61B | 6.24B | 6.84B | 5.79B |
| Net Income | 3.20B | 1.72B | 1.47B | 2.52B | 3.15B | 1.75B |
Balance Sheet | ||||||
| Total Assets | 97.10B | 90.48B | 91.19B | 87.94B | 85.29B | 83.94B |
| Cash, Cash Equivalents and Short-Term Investments | 21.81B | 19.23B | 19.07B | 22.53B | 22.78B | 22.86B |
| Total Debt | 8.24B | 7.18B | 5.76B | 4.55B | 5.29B | 7.87B |
| Total Liabilities | 37.56B | 33.38B | 34.52B | 32.08B | 30.65B | 31.18B |
| Stockholders Equity | 59.54B | 57.10B | 56.67B | 55.86B | 54.64B | 52.76B |
Cash Flow | ||||||
| Free Cash Flow | 4.70B | 1.06B | -1.18B | 2.63B | 4.09B | 1.79B |
| Operating Cash Flow | 7.11B | 4.35B | 2.43B | 4.30B | 5.78B | 2.66B |
| Investing Cash Flow | -2.95B | -4.50B | -5.36B | -2.29B | -2.62B | -1.60B |
| Financing Cash Flow | 68.00M | 251.00M | -572.00M | -2.02B | -3.64B | 1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥19.98B | 9.88 | ― | 3.46% | 3.75% | 4.90% | |
77 Outperform | ¥190.81B | 17.98 | ― | 3.41% | 3.85% | 42.23% | |
76 Outperform | ¥504.07B | 11.76 | 8.51% | 2.25% | 3.33% | 8.79% | |
76 Outperform | ¥173.98B | 11.81 | ― | 4.91% | 3.72% | 14.20% | |
75 Outperform | ¥32.34B | 3.81 | ― | 3.56% | 3.14% | 155.58% | |
67 Neutral | ¥66.59B | 12.84 | 1.61% | 2.27% | 0.82% | -30.81% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |